Showing results (1311-1320 of 1,469) with videos related to
Sort By:
Pageof 147
Neurology(R) Neuroimmunology & Neuroinflammation|January 20, 2022
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control StudyPietro Iaffaldano, Giuseppe Lucisano, Alessia Manni, et al.Nature Communications|January 12, 2022
Comparing ultrastable lasers at 7 × 10-17 fractional frequency instability through a 2220 km optical fibre networkM Schioppo, J Kronjäger, A Silva, et al.EFSA Journal. European Food Safety Authority|July 15, 2025
Peer review of the pesticide risk assessment of the active substance maleic hydrazide, Sofia Batista Leite, Marco Binaglia, et al.EFSA Journal. European Food Safety Authority|May 1, 2025
Peer review of the pesticide risk assessment for the active substance etoxazole in light of confirmatory data on the endocrine disruption assessment, Fernando Álvarez, Maria Arena, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 7, 2024
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched studyClara G Chisari, Umberto Aguglia, Maria Pia Amato, et al.Journal of Neurology|May 28, 2024
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progressionEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.JAMA|April 11, 2013
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancerMingzhao Xing, Ali S Alzahrani, Kathryn A Carson, et al.Geroscience|June 24, 2026
Associations of daily step counts with cognitive, clinical, and resting-state electroencephalographic measures in patients with cognitive decline due to Alzheimer's diseaseMatteo Carpi, Mina De Bartolo, Veronica Henao Isaza, et al.EFSA Journal. European Food Safety Authority|December 8, 2021
Re-evaluation of thaumatin (E 957) as food additive, Maged Younes, Gabriele Aquilina, et al.Brain : a Journal of Neurology|September 16, 2020
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosisMaria Pia Amato, Mattia Fonderico, Emilio Portaccio, et al.Pageof 147